With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
![Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1554213706/Pumalounging.jpg/Pumalounging.jpg?VersionId=AXzRJpBb66kBzE1ipO.16_8WJAXmXjo2)
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
![Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/uploads/2021/4/25/saupload_U22pq7urChUehpbRybf77rsWHgCPpfVvXu7oYf2ZN_d-7JloxsNAgsVg2jM83Fu9d9wZ7AeHZ50Z_aaZx0fQvHiIqA2Wer-bij4NvomBpxAl7EoVzrz6xGcE-wQGAkMHlYvVY4Rd.png)
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
![Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal](https://d3evu7qlt2vui6.cloudfront.net/wp-content/uploads/2021/11/Auerbach.jpg)
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
![Price-Forecasting Models for Puma Biotechnology PBYI Stock: Ta, Ton Viet: 9798457684041: Amazon.com: Books Price-Forecasting Models for Puma Biotechnology PBYI Stock: Ta, Ton Viet: 9798457684041: Amazon.com: Books](https://m.media-amazon.com/images/I/41l6lPDpGOL._AC_SY780_.jpg)